Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;17(5):352-60.
doi: 10.1631/jzus.B1500305.

Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer

Affiliations

Increasing the immune activity of exosomes: the effect of miRNA-depleted exosome proteins on activating dendritic cell/cytokine-induced killer cells against pancreatic cancer

Ri-Sheng Que et al. J Zhejiang Univ Sci B. 2016 May.

Abstract

Background: Tumor-derived exosomes were considered to be potential candidates for tumor vaccines because they are abundant in immune-regulating proteins, whereas tumor exosomal miRNAs may induce immune tolerance, thereby having an opposite immune function.

Objective: This study was designed to separate exosomal protein and depleted exosomal microRNAs (miRNAs), increasing the immune activity of exosomes for activating dendritic cell/cytokine-induced killer cells (DC/CIKs) against pancreatic cancer (PC).

Methods: PC-derived exosomes (PEs) were extracted from cultured PANC-1 cell supernatants and then ruptured; this was followed by ultrafiltered exosome lysates (UELs). DCs were stimulated with lipopolysaccharide (LPS), PE, and UEL, followed by co-culture with CIKs. The anti-tumor effects of DC/CIKs against PC were evaluated by proliferation and killing rates, tumor necrosis factor-α (TNF-α) and perforin secretion. Exosomal miRNAs were depleted after lysis and ultrafiltration, while 128 proteins were retained, including several immune-activating proteins.

Results: UEL-stimulated DC/CIKs showed a higher killing rate than LPS- and PE-stimulated DC/CIKs.

Conclusions: miRNA-depleted exosome proteins may be promising agonists for specifically activating DC/CIKs against PC.

Keywords: Dendritic cell; Exosome; MicroRNAs; Pancreatic cancer.

PubMed Disclaimer

Conflict of interest statement

Compliance with ethics guidelines: Ri-sheng QUE, Cheng LIN, Guo-ping DING, Zheng-rong WU, and Li-ping CAO declare that they have no conflict of interest.

This article does not contain any studies with human or animal subjects performed by any of the authors.

Figures

Fig. 1
Fig. 1
PANC-1-derived exosome (a) and ultrafiltered exosome lysate (b) viewed under electron microscopy
Fig. 2
Fig. 2
Exosomal and UEL RNA electrophoresis PANC-1 exosomes contained integral 28S RNA, 18S RNA, and miRNAs, while miRNAs in UEL were depleted and mRNA was degraded after ultrafiltration. M: RNA markers; E: exosomal RNA; U: UEL RNA
Fig. 3
Fig. 3
Western blot of TNF-α(a) and perforin (b) in LPS-DCs-CIKs, PE-DCs-CIKs and UEL-DCs-CIKs L: LPS-DCs-CIKs; P: PE-DCs-CIKs; U: UEL-DCs-CIKs. TNF-α and perforin were observed in the three CIK groups. Strong expressions of both proteins were observed in LPS- and UEL-DCs-CIKs, while moderate expression was detected in PE-DCs-CIKs

Comment in

References

    1. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32(3-4):623–642. (Available from: http://dx.doi.org/10.1007/s10555-013-9441-9) - DOI - PMC - PubMed
    1. Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, et al. Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett. 2007;113(2):76–82. (Available from: http://dx.doi.org/10.1016/j.imlet.2007.07.014) - DOI - PubMed
    1. Chen J, Ding G, Chen W. The anti-tumor activity of DC/CTL induced by cholangiocarcinoma derived exosome and its ultrafiltered lysate. Chin J Exp Surg. 2013;30:2258–2261.
    1. Chung MJ, Park JY, Bang S, et al. Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer. Cancer Immunol Immunother. 2014;63(9):939–946. (Available from: http://dx.doi.org/10.1007/s00262-014-1566-3) - DOI - PMC - PubMed
    1. Duke-Cohan JS, Tang W, Schlossman SF. Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. In: Langner J, Ansorge S, editors. Cellular Peptidases in Immune Functions and Diseases 2. US: Springer; 2002. pp. 173–185. (Available from: http://dx.doi.org/10.1007/0-306-46826-3_20) - DOI - PubMed

MeSH terms